Data that were cross-referenced to monitor all-cause mortality between death records and laboratory diagnoses in the United Kingdom showed that liver disease is reduced once treatment for hepatitis C virus (HCV) infection is implemented, but researchers believe more research is needed to meet the World Health Organization’s global HCV elimination goal.
Positive results with respect to the presence of latent tuberculosis infection in patients with renal failure were more consistent with the use of QuantiFERON-TB Gold Plus testing compared with the use of QuantiFERON-TB Gold In-Tube testing.
Researchers found data showing that long-term use of tenofovir disoproxil fumarate for hepatitis B virus was not effective, with a low HBeAg seroconversion rate, and that patients presented with a decrease in renal function and bone mineral density.
Based on the 2016 International Working Group (IWG) diagnostic criteria for idiopathic pulmonary fibrosis (IPF), outcomes are relatively similar between patients with IPF with pneumonia and patients with an acute IPF exacerbation.
Researchers found data that were inconclusive for patients who are at risk of having their hepatitis B reactivated because of biologic treatment or chemotherapy and who were being evaluated with the Fujirebio Lumipulse G HBcrAg immunoassay.